Login / Signup
The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research.
Timothy M Dempsey
Andrew H Limper
Published in:
American journal of respiratory and critical care medicine (2023)
Keyphrases
</>
idiopathic pulmonary fibrosis
phase iii
study protocol
interstitial lung disease
phase ii
clinical trial
randomized controlled trial
systemic sclerosis